Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases
Armin Schnabel
*
, Michael Reuter, Wolfgang L. Gross
*
Corresponding author for this work
Clinic of Rheumatology
University of Kiel
143
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Body Surface
20%
Cyclophosphamide
100%
Cyclosporine
20%
High-Resolution Computed Tomography
40%
Interstitial Lung Disease
40%
Lung
20%
Lung Lavage
60%
Neutrophil
20%
Pulse Rate
100%
Sjoegren Syndrome
20%
Treatment of Interstitial Lung Disease
100%
Immunology and Microbiology
Azathioprine
20%
Body Surface
20%
Ciclosporin
20%
Computer Assisted Tomography
40%
Lymphocyte
20%
Maintenance Drug Dose
20%
Neutrophil
20%
Polymyositis
20%
Prednisolone
20%
Sjögren's Syndrome
20%
Surface Area
20%
Systemic Lupus Erythematosus
20%
Systemic Scleroderma
20%
Pharmacology, Toxicology and Pharmaceutical Science
Azathioprine
20%
Hydroxychloroquine
20%
Prednisolone
20%
Remission
20%
Sjoegren Syndrome
20%
Systemic Sclerosis
20%